Angiotensin II and abdominal aortic aneurysms

Current Hypertension Reports

Volumn 6, Issue 6, 2004, Pages 442-446

  Daugherty, Alan ^a   Cassis, Lisa ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; APOLIPOPROTEIN E; CHYMASE; DOXYCYCLINE; ESTROGEN; LOSARTAN; LOW DENSITY LIPOPROTEIN RECEPTOR; MATRIX METALLOPROTEINASE; OSTEOPONTIN; RENIN INHIBITOR; UROKINASE;

ABDOMINAL AORTA ANEURYSM; AGING; DISEASE COURSE; EVIDENCE BASED MEDICINE; GENE FUNCTION; MOLECULAR MECHANICS; MORBIDITY; MORTALITY; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SURGICAL TECHNIQUE;

EID: 10044268384     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0038-0     Document Type: Review

References (42)

1. Rutherford RB, Krupski WC: Current status of open versus endovascular stent-graft repair of abdominal aortic aneurysm. J Vasc Surg 2004, 39:1129-1139.
2. owell JT, Greenhalgh RM: Small abdominal aortic aneurysms N Engl J Med 2003, 348:1895-1901.
3. Thompson MM, Bell PR: ABC of arterial and venous disease: arterial aneurysms. BMJ 2000, 320:1193-1196.
4. Danser AH: Local renin-angiotensin systems: the unanswered questions. Int J Biochem Cell Biol 2003, 35:759-768.
5. Huang W, Alhenc Gelas F, Osborne-Pellegrin MJ: Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat. Circ Res 1998, 82: 79-890.
6. Nishijo N, Sugiyama F, Kimoto K, et al.: Salt-sensitive aortic aneurysm and rupture in hypertensive transgenic mice that overproduce angiotensin II. Lab Invest 1998, 78: 059-1066.
7. Daugherty A, Cassis L: Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor-/- mice. Ann NY Acad Sci 1999, 892:108-118.
8. Daugherty A, Manning MW, Cassis LA: Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000, 105:1605-1612.
9. Deng GG, Martin-McNulty B, Sukovich DA, et al.: Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 2003, 92: 10-517.
10. Cassis LA, Helton MJ, Howatt D, et al.: Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. 2004, In press.
11. Saraff K, Babamusta F, Cassis LA, Daugherty A: Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:1621-1626.
12. owell JT, Brady AR: Detection, management, and prospects for the medical treatment of small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004, 24:241-245.
13. Daugherty A, Cassis LA: Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004, 24:429-434.
14. Manning MW, Cassis LA, Huang J, et al.: Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease Vasc Med 2002, 7:45-54.
15. Henriques TA, Huang J, D'Souza SS, et al.: Orchiectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice. Endocrinology 2004, 145:3866-3872.
16. Martin McNulty B, Tham DM, daCunha V, et al.: 17 beta-estradiol attenuates development of angiotensin II induced aortic abdominal aneurysm in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:1627-1632.
17. Daugherty A, Manning MW, Cassis LA: Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 2001, 134:865-870.
18. Zhou Y, Chen Y, Dirksen WP, et al.: AT1b receptor predominantly mediates contractions in major mouse blood vessels. Circ Res 2003, 93:1089-1094.
19. Daugherty A, Rateri DL, Lu H, et al.: Deficiency of AT1a receptors decreases hypercholesterolemic induced atherosclerosis: association with stimulation of both local and systemic renin-angiotensin systems. 2004, In press.
20. Siragy HM, Carey RM: Angiotensin type 2 receptors: potential importance in the regulation of blood pressure. Curr Opin Nephrol Hypertens 2001, 10:99-103.
21. Strawn WB, Chappell MC, Dean RH, et al.: Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 2000, 101:1586-1593.
22. Daugherty A, Rateri DL, Inagami T, Cassis LA: PD123319 augments atherosclerosis and abdominal aortic aneurysm formation through AT2 receptor-independent mechanisms. 2004, In press.
23. Wang YX, Martin McNulty B, Freay AD, et al.: Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol 2001, 159:1455-1464.
24. Manning MW, Cassis LA, Daugherty A: Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2003, 23:483-488.
25. Bruemmer D, Collins AR, Noh G, et al.: Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest 2003, 112: 318-1331.
26. Anidjar S, Salzmann JL, Gentric D, et al.: Elastase-induced experimental aneurysms in rats. Circulation 1990, 82:973-981.
27. Pyo R, Lee JK, Shipley JM, et al.: Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000, 105:1641-1649.
28. Liao S, Miralles M, Kelley BJ, et al.: Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg 2001, 33:1057-1064.
29. Daugherty A, Ravisankar F, Szilvassy SJ, et al.: Deficiency of CCR2 reduces angiotensin II-induced atherosclerosis and aneurysm formation in apolipoprotein E-/- mice. Arterioscler Thromb Vasc Biol 2004, In press.
30. Miralles M, Wester W, Sicard GA, et al.: Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. J Vasc Surg 1999, 29:884-893.
31. Walton LJ, Franklin IJ, Bayston T, et al.: Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability; inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation 1999, 100:48-54.
32. Hu ZW, Kerb R, Shi XY, et al.: Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. J Pharmacol Exp Ther 2002, 303:563-573.
33. Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST: Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am J Physiol 2004, 286:C779-C784.
34. Vaughan DE, Lazos SA, Tong K: Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells: a potential link between the renin-angiotensin system and thrombosis. J Clin Invest 1995, 95:995-1001.
35. Nishimoto M, Takai S, Fukumoto H, et al.: Increased local angiotensin II formation in aneurysmal aorta. Life Sci 2002, 71:2195-2205.
36. Hamano K, Ohishi M, Ueda M, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is not a risk factor predisposing to abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 1999, 18:158-161.
37. Yeung JM, Heeley M, Gray S, et al.: Does the angiotensin-converting enzyme (ACE) gene polymorphism affect rate of abdominal aortic aneurysm expansion? Eur J Vasc Endovasc Surg 2002, 24:69-71.
38. Pola R, Gaetani E, Santoliquido A, et al.: Abdominal aortic aneurysm in normotensive patients: association with angiotensin-converting enzyme gene polymorphism. Eur J Vasc Endovasc Surg 2001, 21:445-449.
39. Wilmink AB, Vardulaki KA, Hubbard CS, et al.: Are antihypertensive drugs associated with abdominal aortic aneurysms? J Vasc Surg 2002, 36:751-757.
40. Ejiri J, Inoue N, Tsukube T, et al.: Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker. Cardiovasc Res 2003, 59:988-996.
41. Thompson RW, Baxter BT: MMP inhibition in abdominal aortic aneurysms: rationale for a prospective randomized clinical trial. Ann NY Acad Sci 1999, 878:159-178.
42. Stanton A: Potential of renin inhibition in cardiovascular disease. J Renin Angiotensin Aldosterone Syst 2003, 4: -10.